Levodopa–carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry

AIM: To evaluate long-term effects of levodopa–carbidopa intestinal gel on dyskinesia burden. PATIENTS & METHODS: Posthoc analysis of the GLORIA registry assessed subgroups of advanced Parkinson's disease patients with <4 and ≥4 h/day of levodopa-induced dyskinesia at baseline. RESULTS &...

Descripción completa

Detalles Bibliográficos
Autores principales: Poewe, Werner, Chaudhuri, K Ray, Bergmann, Lars, Antonini, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360350/
https://www.ncbi.nlm.nih.gov/pubmed/30547712
http://dx.doi.org/10.2217/nmt-2018-0034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360350/
https://www.ncbi.nlm.nih.gov/pubmed/30547712
http://dx.doi.org/10.2217/nmt-2018-0034

Ejemplares similares